Zomedica Statistics
Total Valuation
Zomedica has a market cap or net worth of 49.05 million. The enterprise value is -20.49 million.
| Market Cap | 49.05M |
| Enterprise Value | -20.49M |
Important Dates
The last earnings date was Thursday, March 13, 2025.
| Earnings Date | Mar 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zomedica has 979.95 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 9.34% |
| Float | 961.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.80 |
| PB Ratio | 0.25 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.44 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.71 |
Financial Position
The company has a current ratio of 8.76, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.76 |
| Quick Ratio | 7.98 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.06 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.57% and return on invested capital (ROIC) is -9.95%.
| Return on Equity (ROE) | -21.57% |
| Return on Assets (ROA) | -9.51% |
| Return on Invested Capital (ROIC) | -9.95% |
| Return on Capital Employed (ROCE) | -17.69% |
| Revenue Per Employee | 189,479 |
| Profits Per Employee | -326,264 |
| Employee Count | 144 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 1.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.03% in the last 52 weeks. The beta is 1.16, so Zomedica's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -64.03% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 30.24 |
| Average Volume (20 Days) | 13,814,343 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zomedica had revenue of 27.29 million and -46.98 million in losses. Loss per share was -0.05.
| Revenue | 27.29M |
| Gross Profit | 19.09M |
| Operating Income | -35.03M |
| Pretax Income | -47.54M |
| Net Income | -46.98M |
| EBITDA | -27.04M |
| EBIT | -35.03M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 71.35 million in cash and 1.81 million in debt, giving a net cash position of 69.54 million or 0.07 per share.
| Cash & Cash Equivalents | 71.35M |
| Total Debt | 1.81M |
| Net Cash | 69.54M |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 195.66M |
| Book Value Per Share | 0.20 |
| Working Capital | 72.44M |
Cash Flow
In the last 12 months, operating cash flow was -23.63 million and capital expenditures -5.21 million, giving a free cash flow of -28.84 million.
| Operating Cash Flow | -23.63M |
| Capital Expenditures | -5.21M |
| Free Cash Flow | -28.84M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 69.95%, with operating and profit margins of -128.38% and -172.19%.
| Gross Margin | 69.95% |
| Operating Margin | -128.38% |
| Pretax Margin | -174.23% |
| Profit Margin | -172.19% |
| EBITDA Margin | -99.11% |
| EBIT Margin | -128.38% |
| FCF Margin | n/a |
Dividends & Yields
Zomedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -95.79% |
| FCF Yield | -58.81% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |